The prognostic value of plasma NGAL for distinguishing between WRF and good vs. poor prognosis was examined for adjudicated endpoints of 180-day mortality and a composite of 60-day death or renal or cardiovascular rehospitalization. WRF with good vs. poor outcome was defined based on whether patients experienced either of the clinical endpoints.